1. The Role Of Body Mass Index In Survival Outcome For Lymphoma Patients: US Intergroup Experience
by Fangxin Hong, Thomas M Habermann, Leo I. Gordon, Howard S Hochster, Randy D. Gascoyne, Vicki A. Morrison, Richard I Fisher, Nancy L. Bartlett, Patrick J Stiff, Bruce D. Cheson, Michael Crump, Sandra J. Horning, and Brad S. Kahl
Blood
Volume 122(21):
November 15, 2013
©2013 by American Society of Hematology

2. FFS (A) and OS (B) by BMI groups, for DLBCL patients (A1, B1), for the HL patients (A2, B2) and the FL patients (A3, B3).
FFS (A) and OS (B) by BMI groups, for DLBCL patients (A1, B1), for the HL patients (A2, B2) and the FL patients (A3, B3).
Thomas M Habermann et al. Blood 2013;122:3060
©2013 by American Society of Hematology

3. OS by BMI groups, for female patients (A) and male patients (B) stratified on treatment arms, female patients (C) and male patients (D) treated with RCHOP, in the E4494 (DLBCL) trial.
OS by BMI groups, for female patients (A) and male patients (B) stratified on treatment arms, female patients (C) and male patients (D) treated with RCHOP, in the E4494 (DLBCL) trial.
Thomas M Habermann et al. Blood 2013;122:3060
©2013 by American Society of Hematology